EA201300380A1 - Рекомбинантная mycobacterium в качестве вакцины для применения у людей - Google Patents

Рекомбинантная mycobacterium в качестве вакцины для применения у людей

Info

Publication number
EA201300380A1
EA201300380A1 EA201300380A EA201300380A EA201300380A1 EA 201300380 A1 EA201300380 A1 EA 201300380A1 EA 201300380 A EA201300380 A EA 201300380A EA 201300380 A EA201300380 A EA 201300380A EA 201300380 A1 EA201300380 A1 EA 201300380A1
Authority
EA
Eurasian Patent Office
Prior art keywords
vaccine
people
recombinant mycobacterium
mycobacterium
recombinant
Prior art date
Application number
EA201300380A
Other languages
English (en)
Other versions
EA026661B1 (ru
Inventor
Леандер Гроде
Original Assignee
Вакцине Проект Менеджмент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вакцине Проект Менеджмент Гмбх filed Critical Вакцине Проект Менеджмент Гмбх
Publication of EA201300380A1 publication Critical patent/EA201300380A1/ru
Publication of EA026661B1 publication Critical patent/EA026661B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Изобретение относится к новой рекомбинантной вакцине, обеспечивающей защитный иммунитет, в особенности, против туберкулеза у людей.
EA201300380A 2010-09-20 2011-09-16 Вакцина и способ вакцинации против туберкулеза EA026661B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38437510P 2010-09-20 2010-09-20
PCT/EP2011/066131 WO2012038348A1 (en) 2010-09-20 2011-09-16 Recombinant mycobacterium as vaccine for use in humans

Publications (2)

Publication Number Publication Date
EA201300380A1 true EA201300380A1 (ru) 2013-07-30
EA026661B1 EA026661B1 (ru) 2017-05-31

Family

ID=44645725

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300380A EA026661B1 (ru) 2010-09-20 2011-09-16 Вакцина и способ вакцинации против туберкулеза

Country Status (26)

Country Link
US (1) US9084749B2 (ru)
EP (2) EP3360569B1 (ru)
JP (1) JP5919276B2 (ru)
KR (1) KR101907222B1 (ru)
CN (1) CN103118703A (ru)
AU (1) AU2011304385B2 (ru)
BR (1) BR112013006245A2 (ru)
CA (1) CA2811158C (ru)
CU (1) CU24182B1 (ru)
CY (2) CY1120748T1 (ru)
DK (2) DK2618837T3 (ru)
EA (1) EA026661B1 (ru)
ES (2) ES2685928T3 (ru)
HK (1) HK1258603A1 (ru)
HR (2) HRP20181387T1 (ru)
HU (2) HUE039038T2 (ru)
LT (2) LT3360569T (ru)
MX (1) MX346708B (ru)
PL (2) PL2618837T3 (ru)
PT (2) PT3360569T (ru)
RS (2) RS60146B1 (ru)
SG (1) SG188595A1 (ru)
SI (2) SI2618837T1 (ru)
UA (1) UA112297C2 (ru)
WO (1) WO2012038348A1 (ru)
ZA (1) ZA201301187B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2654783T3 (pl) 2010-12-21 2017-08-31 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Rekombinowane Mycobacterium jako szczepionka
EP3090757A1 (en) 2015-05-04 2016-11-09 Vakzine Projekt Management GmbH Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer
KR102338845B1 (ko) 2020-05-22 2021-12-13 서울대학교산학협력단 플랩 구동 장치 및 회전익기의 블레이드

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733151A (en) 1996-08-23 1998-03-31 Edsall; David Electrical clamping connection device
AUPO761697A0 (en) 1997-06-30 1997-07-24 Cardiac Crc Nominees Pty Limited Process for the purification of polyethers
EP0902086A1 (en) * 1997-08-22 1999-03-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine
CN1513551A (zh) * 2002-09-09 2004-07-21 丛繁滋 复合生物制品组合物及其制备方法
ATE473238T1 (de) 2003-04-23 2010-07-15 Max Planck Gesellschaft Tuberkulose vaccine mit verbesserter effizienz
EP1649869A1 (en) 2004-10-21 2006-04-26 Vakzine Projekt Management GmbH Combination of a recombinant mycobacterium and a biologically active agent as a vaccine

Also Published As

Publication number Publication date
PL3360569T3 (pl) 2020-07-27
KR20140017484A (ko) 2014-02-11
CA2811158C (en) 2019-06-25
SG188595A1 (en) 2013-04-30
CU24182B1 (es) 2016-07-29
UA112297C2 (uk) 2016-08-25
ZA201301187B (en) 2013-09-25
HRP20200610T1 (hr) 2020-10-02
HUE048774T2 (hu) 2020-08-28
MX346708B (es) 2017-03-29
RS57574B1 (sr) 2018-11-30
CN103118703A (zh) 2013-05-22
JP2013538225A (ja) 2013-10-10
CY1123049T1 (el) 2021-10-29
CU20130041A7 (es) 2013-06-28
US20130280287A1 (en) 2013-10-24
US9084749B2 (en) 2015-07-21
EP3360569B1 (en) 2020-03-18
HK1258603A1 (zh) 2019-11-15
HRP20181387T1 (hr) 2018-11-02
SI3360569T1 (sl) 2020-07-31
PT2618837T (pt) 2018-10-18
EP2618837A1 (en) 2013-07-31
EP2618837B1 (en) 2018-08-08
WO2012038348A1 (en) 2012-03-29
LT2618837T (lt) 2018-09-25
PT3360569T (pt) 2020-04-17
KR101907222B1 (ko) 2018-10-11
EA026661B1 (ru) 2017-05-31
CY1120748T1 (el) 2019-12-11
RS60146B1 (sr) 2020-05-29
AU2011304385B2 (en) 2015-02-26
AU2011304385A1 (en) 2013-03-21
HUE039038T2 (hu) 2018-12-28
CA2811158A1 (en) 2012-03-29
JP5919276B2 (ja) 2016-05-18
PL2618837T3 (pl) 2018-11-30
LT3360569T (lt) 2020-05-11
EP3360569A1 (en) 2018-08-15
SI2618837T1 (sl) 2018-11-30
DK3360569T3 (da) 2020-04-06
MX2013002989A (es) 2013-10-17
DK2618837T3 (en) 2018-10-01
ES2685928T3 (es) 2018-10-15
BR112013006245A2 (pt) 2016-06-07
ES2784451T3 (es) 2020-09-25

Similar Documents

Publication Publication Date Title
MY169141A (en) Biodegradable compositions, methods and uses thereof
EA201070219A1 (ru) Полимерные мультиэпитопные вакцины против гриппа
DK3459966T3 (da) Ny recombinant bordetella strain
PE20151435A1 (es) Laquinimod para reducir el dano talamico en la esclerosis multiple
TR201905787T4 (tr) Liyofilize TAT-NR2B9C formülasyonu.
CY1118539T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο
CY1123049T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους
MY175307A (en) Preparations comprising amorphous emodepside
IT1400227B1 (it) Molla di contatto per contatto di sicurezza e contatto di sicurezza comprendente tale molla
HK1209027A1 (en) Vesicular formulations, uses and methods
GB201208409D0 (en) Vesicular formulations, kits and uses
MX2013008559A (es) Derivados de leptina.
GB201106162D0 (en) Combination vaccine
MX345739B (es) Nuevo adyuvante.
MX2015009161A (es) Polioles, su preparación y su uso.
IT1399581B1 (it) Dispositivo per la protezione di parti del corpo di un individuo, in particolare per la protezione della schiena.
AU345549S (en) A cape
GB201208360D0 (en) Vesicular formulations,kits and uses
GB2515669A (en) Bacterial vaccine
UA23053S (uk) Вивіска «м. оливье»
GB201108311D0 (en) The grabbgo. Hot hand protector
RU2012123634A (ru) Применение аналога альфа-конотоксина phia в качестве анальгетика
CL2009000813S1 (es) Estructura protectora.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM